Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Spironolactone Tablets

Approval Number

国药准字H20227135

Company浙江神洲药业有限公司

Registration Date

October 18, 2022

Previous Approval Numbers

国药准字H20213667

Drug Information

Generic Name

螺内酯片

Dosage Form

片剂

Strength

20mg

Drug Type

化学药品

Registration Date

October 18, 2022

Company Information

Applicant Company

Company Name浙江神洲药业有限公司

Company Address

浙江省台州市仙居县福应街道现代工业集聚区鸿运路9号

Manufacturing Company

Company Name浙江神洲药业有限公司

Company Address

浙江省台州市仙居县福应街道现代工业集聚区鸿运路2号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

螺内酯片 - NMPA 批准文号 | MedPath